Use of a living dermal equivalent for a refractory abdominal defect after pediatric multivisceral transplantation

Carlos A. Charles, Tomoaki Kato, Andreas G. Tzakis, Barbara N. Miller, Robert Kirsner

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

BACKGROUND. Primary closure is not always possible after pediatric multivisceral transplantation. Reepithelialization may require extended periods of postoperative time, which can be associated with significant morbidity. OBJECTIVE. The objective was to accelerate secondary wound closure thereby minimizing infection or further complications in a pediatric multivisceral transplant patient. METHODS. Five applications of human fibroblast-derived dermis (Dermagraft, Smith and Nephew) were applied to the postsurgical defect of a pediatric multivisceral transplant patient over the course of 8 months. Routine wound care and observation was performed between human fibroblast-derived dermis applications. RESULTS. Human fibroblast-derived dermis stimulated healing and accelerated reepithelialization. Signs of clinical rejection or infection were not observed. CONCLUSION. Reepithelialization can be aided in the postoperative period in pediatric multivisceral transplant patients with human fibroblast-derived dermis, thereby helping to deter complications associated with secondary wound closure. We have illustrated the successful use of a human fibroblast-derived dermis as an adjunct for wound healing in a complicated surgical defect.

Original languageEnglish
Pages (from-to)1236-1240
Number of pages5
JournalDermatologic Surgery
Volume30
Issue number9
DOIs
StatePublished - Sep 1 2004

Fingerprint

Dermis
Fibroblasts
Transplantation
Pediatrics
Skin
Transplants
Postoperative Period
Wounds and Injuries
Infection
Wound Healing
Observation
Morbidity

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

Use of a living dermal equivalent for a refractory abdominal defect after pediatric multivisceral transplantation. / Charles, Carlos A.; Kato, Tomoaki; Tzakis, Andreas G.; Miller, Barbara N.; Kirsner, Robert.

In: Dermatologic Surgery, Vol. 30, No. 9, 01.09.2004, p. 1236-1240.

Research output: Contribution to journalArticle

Charles, Carlos A. ; Kato, Tomoaki ; Tzakis, Andreas G. ; Miller, Barbara N. ; Kirsner, Robert. / Use of a living dermal equivalent for a refractory abdominal defect after pediatric multivisceral transplantation. In: Dermatologic Surgery. 2004 ; Vol. 30, No. 9. pp. 1236-1240.
@article{5d68ccdb5f4c4e8291cb0e275c2a547e,
title = "Use of a living dermal equivalent for a refractory abdominal defect after pediatric multivisceral transplantation",
abstract = "BACKGROUND. Primary closure is not always possible after pediatric multivisceral transplantation. Reepithelialization may require extended periods of postoperative time, which can be associated with significant morbidity. OBJECTIVE. The objective was to accelerate secondary wound closure thereby minimizing infection or further complications in a pediatric multivisceral transplant patient. METHODS. Five applications of human fibroblast-derived dermis (Dermagraft, Smith and Nephew) were applied to the postsurgical defect of a pediatric multivisceral transplant patient over the course of 8 months. Routine wound care and observation was performed between human fibroblast-derived dermis applications. RESULTS. Human fibroblast-derived dermis stimulated healing and accelerated reepithelialization. Signs of clinical rejection or infection were not observed. CONCLUSION. Reepithelialization can be aided in the postoperative period in pediatric multivisceral transplant patients with human fibroblast-derived dermis, thereby helping to deter complications associated with secondary wound closure. We have illustrated the successful use of a human fibroblast-derived dermis as an adjunct for wound healing in a complicated surgical defect.",
author = "Charles, {Carlos A.} and Tomoaki Kato and Tzakis, {Andreas G.} and Miller, {Barbara N.} and Robert Kirsner",
year = "2004",
month = "9",
day = "1",
doi = "10.1111/j.1524-4725.2004.30383.x",
language = "English",
volume = "30",
pages = "1236--1240",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Use of a living dermal equivalent for a refractory abdominal defect after pediatric multivisceral transplantation

AU - Charles, Carlos A.

AU - Kato, Tomoaki

AU - Tzakis, Andreas G.

AU - Miller, Barbara N.

AU - Kirsner, Robert

PY - 2004/9/1

Y1 - 2004/9/1

N2 - BACKGROUND. Primary closure is not always possible after pediatric multivisceral transplantation. Reepithelialization may require extended periods of postoperative time, which can be associated with significant morbidity. OBJECTIVE. The objective was to accelerate secondary wound closure thereby minimizing infection or further complications in a pediatric multivisceral transplant patient. METHODS. Five applications of human fibroblast-derived dermis (Dermagraft, Smith and Nephew) were applied to the postsurgical defect of a pediatric multivisceral transplant patient over the course of 8 months. Routine wound care and observation was performed between human fibroblast-derived dermis applications. RESULTS. Human fibroblast-derived dermis stimulated healing and accelerated reepithelialization. Signs of clinical rejection or infection were not observed. CONCLUSION. Reepithelialization can be aided in the postoperative period in pediatric multivisceral transplant patients with human fibroblast-derived dermis, thereby helping to deter complications associated with secondary wound closure. We have illustrated the successful use of a human fibroblast-derived dermis as an adjunct for wound healing in a complicated surgical defect.

AB - BACKGROUND. Primary closure is not always possible after pediatric multivisceral transplantation. Reepithelialization may require extended periods of postoperative time, which can be associated with significant morbidity. OBJECTIVE. The objective was to accelerate secondary wound closure thereby minimizing infection or further complications in a pediatric multivisceral transplant patient. METHODS. Five applications of human fibroblast-derived dermis (Dermagraft, Smith and Nephew) were applied to the postsurgical defect of a pediatric multivisceral transplant patient over the course of 8 months. Routine wound care and observation was performed between human fibroblast-derived dermis applications. RESULTS. Human fibroblast-derived dermis stimulated healing and accelerated reepithelialization. Signs of clinical rejection or infection were not observed. CONCLUSION. Reepithelialization can be aided in the postoperative period in pediatric multivisceral transplant patients with human fibroblast-derived dermis, thereby helping to deter complications associated with secondary wound closure. We have illustrated the successful use of a human fibroblast-derived dermis as an adjunct for wound healing in a complicated surgical defect.

UR - http://www.scopus.com/inward/record.url?scp=4744345267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744345267&partnerID=8YFLogxK

U2 - 10.1111/j.1524-4725.2004.30383.x

DO - 10.1111/j.1524-4725.2004.30383.x

M3 - Article

C2 - 15355368

AN - SCOPUS:4744345267

VL - 30

SP - 1236

EP - 1240

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 9

ER -